1 / 7

Pegfilgrastim Biosimilar Market

Pegfilgrastim Biosimilar Market research report covers detailed information on Global Pegfilgrastim Biosimilar Market Size, Share, application, competition and growth opportunities till 2026.<br>

kunal33
Download Presentation

Pegfilgrastim Biosimilar Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Copyright © Fact.MR All Rights Reserved Pegfilgrastim biosimilar Market Analysis Report By Distribution Channel, By Region - Global Market Insights 2020-2026

  2. About Fact.MR Fact.MR (FMR) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMR is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Social Media Research Customized Research Syndicated Research Investment Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas For detailed subscription information please contact Website: www.factmr.com For sales queries or new topics email us on: sales@factmr.com Subscription Information Copyright © Fact.MR All Rights Reserved

  3. ResearchMethodology Research & Intelligence Data Collection Actionable Insights Data Filter & Analysis Business Solution 1 Market profiling 2 Formulating discussion guide • Identifying key opinion leaders • Questionnaire design • In-depth interviews • Coverage across value chain 3 A Developing list of respondents • Key industry experts • Channel study • Developments • Market dynamics • Products • Conclusions Primary Research 4 SOLUTION Data collection • Market participants • Key strengths • Product portfolio • Mapping as per value chain • Key focus segments B 5 Desk Research Data validation 6 C Data analysis Primary Research # • Secondary Research # • Paid Publications# Company Analysis • Linkedin • Zoominfo • Salesforce • Avention • Company websites • Company annual reports • White papers • Financial reports • Factiva • GBI • Genios • Meltwater 7 Insights Systematic Research Approach Copyright © Fact.MR All Rights Reserved

  4. Report Scope & Segmentation Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in the market. Pegfilgrastim is used as a supportive oncology drug to treat chemotherapy- and/or radiotherapy-induced neutropenia in cancer patients. With more than ten pegfilgrastimbiosimilars available in the market and over 5 under development, the pegfilgrastim biosimilar size market is expected to witness an upswing in the future. Report Scope Digital Remittance Copyright © Fact.MR All Rights Reserved

  5. Regional Outlook of Pegfilgrastim Biosimilar Market The pegfilgrastim biosimilar market is segmented into the following regions - North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa. North America is the dominant region that holds over 3/4 of the global pegfilgrastim biosimilar market share. Majority of pegfilgrastim biosimilar developers target North America for their product launches, owing to growing demand for biosimilars in this region. North America has experienced increasing spending on biologics for cancer and related disease treatment over the past few years. Also, rising prevalence of cancer and advanced healthcare facilities make North America the most attractive region for pegfilgrastim biosimilar market players. Get To Know More About The Market Copyright © Fact.MR All Rights Reserved

  6. Competitive Landscape •  Pfizer Inc, • Green Cross Corp, • Accord healthcare • Intas • Pharmaceuticals Ltd, • ZydusCadila Request For Sample Report Copyright © Fact.MR All Rights Reserved

  7. “Setting goals is the first step in turning the invisible into the visible” Website: www.factmr.com For sales queries or new topics email us on: sales@factmr.com For other queries contact:Suite 9884, 27 Upper Pembroke Street,Dublin 2, Ireland Tel: +353-1-6111-593 Copyright © Fact.MR All Rights Reserved

More Related